Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Cancer Supportive Care Medicine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Kyowa Hakko Kirin
Heron Therapeutics
Johnson &Johnson
Amgen
Teva Pharmaceutical Industries
Novartis
Helsinn Healthcare
Merck
TESARO
By Type:
Erythropoietin-Stimulating Agents
Antiemetic Drugs
Granulocyte-Stimulating Agents
Analgesics
Others
By Application:
Others
Bone Metastasis
CINV
Cancer Pain
Chemotherapy-Induced Anemia
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Cancer Supportive Care Medicine Market Overview 2018-2029
-
1.1 China Cancer Supportive Care Medicine Industry Development Overview
-
1.2 China Cancer Supportive Care Medicine Industry Development History
-
1.3 China Cancer Supportive Care Medicine Industry Market Size (2018-2029)
-
1.4 China Cancer Supportive Care Medicine Market Analysis by Type from Production Side
-
1.4.1 China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Erythropoietin-Stimulating Agents (2018-2029)
-
1.4.2 China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Antiemetic Drugs (2018-2029)
-
1.4.3 China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Granulocyte-Stimulating Agents (2018-2029)
-
1.4.4 China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Analgesics (2018-2029)
-
1.4.5 China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Cancer Supportive Care Medicine Market Analysis by Application from Consumption End
-
1.5.1 China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of Bone Metastasis (2018-2029)
-
1.5.3 China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of CINV (2018-2029)
-
1.5.4 China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of Cancer Pain (2018-2029)
-
1.5.5 China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of Chemotherapy-Induced Anemia (2018-2029)
-
1.6 China Cancer Supportive Care Medicine Market Analysis by Region
-
1.6.1 North China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
Chapter 2 China Cancer Supportive Care Medicine Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Cancer Supportive Care Medicine Market Status and Competition at home and abroad in 2023
-
2.2.2 China Cancer Supportive Care Medicine Market Status and Competition Analysis in 2023
-
2.2.3 China Cancer Supportive Care Medicine Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Cancer Supportive Care Medicine Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Cancer Supportive Care Medicine Industry Development
Chapter 3 Cancer Supportive Care MedicineIndustry Chain Analysis
-
3.1 Cancer Supportive Care Medicine Industry Chain
-
3.2 Cancer Supportive Care Medicine Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Cancer Supportive Care Medicine Market
-
3.3 Cancer Supportive Care Medicine Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Cancer Supportive Care Medicine Market
Chapter 4 China Cancer Supportive Care Medicine Market, by Type
-
4.1 China Cancer Supportive Care Medicine Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Cancer Supportive Care Medicine Total Production Volume and Growth Rate from Production Side
-
4.5 China Cancer Supportive Care Medicine Production Volume and Growth Rate, by Type
-
4.5.1 China Cancer Supportive Care Medicine Production Volume and Growth Rate of Erythropoietin-Stimulating Agents
-
4.5.2 China Cancer Supportive Care Medicine Production Volume and Growth Rate of Antiemetic Drugs
-
4.5.3 China Cancer Supportive Care Medicine Production Volume and Growth Rate of Granulocyte-Stimulating Agents
-
4.5.4 China Cancer Supportive Care Medicine Production Volume and Growth Rate of Analgesics
-
4.5.5 China Cancer Supportive Care Medicine Production Volume and Growth Rate of Others
Chapter 5 China Cancer Supportive Care Medicine Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Cancer Supportive Care Medicine Total Market Size and Growth Rate from Consumption End
-
5.5 China Cancer Supportive Care Medicine Market Size and Growth Rate, by Application
-
5.5.1 China Cancer Supportive Care Medicine Market Size and Growth Rate of Others
-
5.5.2 China Cancer Supportive Care Medicine Market Size and Growth Rate of Bone Metastasis
-
5.5.3 China Cancer Supportive Care Medicine Market Size and Growth Rate of CINV
-
5.5.4 China Cancer Supportive Care Medicine Market Size and Growth Rate of Cancer Pain
-
5.5.5 China Cancer Supportive Care Medicine Market Size and Growth Rate of Chemotherapy-Induced Anemia
Chapter 6 China Cancer Supportive Care Medicine Market, by Region
-
6.1 China Cancer Supportive Care Medicine Production Volume and Production Value, by Region
-
6.2 China Cancer Supportive Care Medicine Sales Volume and Sales Value, by Region
Chapter 7 North China Cancer Supportive Care Medicine Market Analysis
-
7.1 North China Cancer Supportive Care Medicine Market, by Type
-
7.2 North China Cancer Supportive Care Medicine Market, by Application
Chapter 8 Central China Cancer Supportive Care Medicine Market Analysis
-
8.1 Central China Cancer Supportive Care Medicine Market, by Type
-
8.2 Central China Cancer Supportive Care Medicine Market, by Application
Chapter 9 South China Cancer Supportive Care Medicine Market Analysis
-
9.1 South China Cancer Supportive Care Medicine Market, by Type
-
9.2 South China Cancer Supportive Care Medicine Market, by Application
Chapter 10 East China Cancer Supportive Care Medicine Market Analysis
-
10.1 East China Cancer Supportive Care Medicine Market, by Type
-
10.2 East China Cancer Supportive Care Medicine Market, by Application
Chapter 11 Northeast China Cancer Supportive Care Medicine Market Analysis
-
11.1 Northeast China Cancer Supportive Care Medicine Market, by Type
-
11.2 Northeast China Cancer Supportive Care Medicine Market, by Application
Chapter 12 Southwest China Cancer Supportive Care Medicine Market Analysis
-
12.1 Southwest China Cancer Supportive Care Medicine Market, by Type
-
12.2 Southwest China Cancer Supportive Care Medicine Market, by Application
Chapter 13 Northwest China Cancer Supportive Care Medicine Market Analysis
-
13.1 Northwest China Cancer Supportive Care Medicine Market, by Type
-
13.2 Northwest China Cancer Supportive Care Medicine Market, by Application
Chapter 14 Company Profiles
-
14.1 Kyowa Hakko Kirin
-
14.1.1 Kyowa Hakko Kirin Company Profile
-
14.1.2 Kyowa Hakko Kirin Cancer Supportive Care Medicine Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Heron Therapeutics
-
14.2.1 Heron Therapeutics Company Profile
-
14.2.2 Heron Therapeutics Cancer Supportive Care Medicine Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Johnson &Johnson
-
14.3.1 Johnson &Johnson Company Profile
-
14.3.2 Johnson &Johnson Cancer Supportive Care Medicine Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amgen
-
14.4.1 Amgen Company Profile
-
14.4.2 Amgen Cancer Supportive Care Medicine Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Teva Pharmaceutical Industries
-
14.5.1 Teva Pharmaceutical Industries Company Profile
-
14.5.2 Teva Pharmaceutical Industries Cancer Supportive Care Medicine Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis
-
14.6.1 Novartis Company Profile
-
14.6.2 Novartis Cancer Supportive Care Medicine Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Helsinn Healthcare
-
14.7.1 Helsinn Healthcare Company Profile
-
14.7.2 Helsinn Healthcare Cancer Supportive Care Medicine Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Merck
-
14.8.1 Merck Company Profile
-
14.8.2 Merck Cancer Supportive Care Medicine Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 TESARO
-
14.9.1 TESARO Company Profile
-
14.9.2 TESARO Cancer Supportive Care Medicine Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Cancer Supportive Care Medicine Industry Research Conclusions
-
15.2 Cancer Supportive Care Medicine Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Cancer Supportive Care Medicine Industry Market Size (2018-2029)
-
Figure China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Erythropoietin-Stimulating Agents (2018-2029)
-
Figure China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Antiemetic Drugs (2018-2029)
-
Figure China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Granulocyte-Stimulating Agents (2018-2029)
-
Figure China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Analgesics (2018-2029)
-
Figure China Cancer Supportive Care Medicine Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of Bone Metastasis (2018-2029)
-
Figure China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of CINV (2018-2029)
-
Figure China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of Cancer Pain (2018-2029)
-
Figure China Cancer Supportive Care Medicine Sales Volume, Sales Value and Growth Rate of Chemotherapy-Induced Anemia (2018-2029)
-
Figure North China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
Figure Central China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
Figure South China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
Figure East China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Cancer Supportive Care Medicine Market Size and Growth Rate from 2018-2029
-
Figure Cancer Supportive Care Medicine Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Cancer Supportive Care Medicine Market Share by Type in 2018
-
Figure China Cancer Supportive Care Medicine Market Share by Type in 2023
-
Figure China Cancer Supportive Care Medicine Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Cancer Supportive Care Medicine Production Volume and Growth Rate of Erythropoietin-Stimulating Agents (2018-2023)
-
Figure China Cancer Supportive Care Medicine Production Volume and Growth Rate of Antiemetic Drugs (2018-2023)
-
Figure China Cancer Supportive Care Medicine Production Volume and Growth Rate of Granulocyte-Stimulating Agents (2018-2023)
-
Figure China Cancer Supportive Care Medicine Production Volume and Growth Rate of Analgesics (2018-2023)
-
Figure China Cancer Supportive Care Medicine Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Cancer Supportive Care Medicine Market Share by Application in 2018
-
Figure China Cancer Supportive Care Medicine Market Share by Application in 2023
-
Figure China Cancer Supportive Care Medicine Total Market Size and Growth Rate from Consumption End
-
Figure China Cancer Supportive Care Medicine Market Size and Growth Rate of Others (2018-2023)
-
Figure China Cancer Supportive Care Medicine Market Size and Growth Rate of Bone Metastasis (2018-2023)
-
Figure China Cancer Supportive Care Medicine Market Size and Growth Rate of CINV (2018-2023)
-
Figure China Cancer Supportive Care Medicine Market Size and Growth Rate of Cancer Pain (2018-2023)
-
Figure China Cancer Supportive Care Medicine Market Size and Growth Rate of Chemotherapy-Induced Anemia (2018-2023)
-
Table China Cancer Supportive Care Medicine Production Volume by Region (2018-2023)
-
Table China Cancer Supportive Care Medicine Production Volume Share by Region (2018-2023)
-
Figure China Cancer Supportive Care Medicine Production Volume Share by Region (2018-2023)
-
Table China Cancer Supportive Care Medicine Production Value by Region (2018-2023)
-
Table China Cancer Supportive Care Medicine Production Value Share by Region (2018-2023)
-
Figure China Cancer Supportive Care Medicine Production Value Share by Region (2018-2023)
-
Table China Cancer Supportive Care Medicine Sales Volume by Region (2018-2023)
-
Table China Cancer Supportive Care Medicine Sales Volume Share by Region (2018-2023)
-
Figure China Cancer Supportive Care Medicine Sales Volume Share by Region (2018-2023)
-
Table China Cancer Supportive Care Medicine Sales Value by Region (2018-2023)
-
Table China Cancer Supportive Care Medicine Sales Value Share by Region (2018-2023)
-
Figure China Cancer Supportive Care Medicine Sales Value Share by Region (2018-2023)
-
Table North China Cancer Supportive Care Medicine Production Volume by Type (2018-2023)
-
Table North China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Figure North China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Table North China Cancer Supportive Care Medicine Sales Volume by Application (2018-2023)
-
Table North China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Figure North China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Table Central China Cancer Supportive Care Medicine Production Volume by Type (2018-2023)
-
Table Central China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Figure Central China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Table Central China Cancer Supportive Care Medicine Sales Volume by Application (2018-2023)
-
Table Central China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Figure Central China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Table South China Cancer Supportive Care Medicine Production Volume by Type (2018-2023)
-
Table South China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Figure South China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Table South China Cancer Supportive Care Medicine Sales Volume by Application (2018-2023)
-
Table South China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Figure South China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Table East China Cancer Supportive Care Medicine Production Volume by Type (2018-2023)
-
Table East China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Figure East China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Table East China Cancer Supportive Care Medicine Sales Volume by Application (2018-2023)
-
Table East China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Figure East China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Table Northeast China Cancer Supportive Care Medicine Production Volume by Type (2018-2023)
-
Table Northeast China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Figure Northeast China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Table Northeast China Cancer Supportive Care Medicine Sales Volume by Application (2018-2023)
-
Table Northeast China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Table Southwest China Cancer Supportive Care Medicine Production Volume by Type (2018-2023)
-
Table Southwest China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Figure Southwest China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Table Southwest China Cancer Supportive Care Medicine Sales Volume by Application (2018-2023)
-
Table Southwest China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Table Northwest China Cancer Supportive Care Medicine Production Volume by Type (2018-2023)
-
Table Northwest China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Figure Northwest China Cancer Supportive Care Medicine Production Volume Share by Type (2018-2023)
-
Table Northwest China Cancer Supportive Care Medicine Sales Volume by Application (2018-2023)
-
Table Northwest China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Cancer Supportive Care Medicine Sales Volume Share by Application (2018-2023)
-
Table Kyowa Hakko Kirin Company Profile
-
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
Table Heron Therapeutics Company Profile
-
Table Heron Therapeutics Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
Table Johnson &Johnson Company Profile
-
Table Johnson &Johnson Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Industries Company Profile
-
Table Teva Pharmaceutical Industries Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
Table Helsinn Healthcare Company Profile
-
Table Helsinn Healthcare Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
Table TESARO Company Profile
-
Table TESARO Cancer Supportive Care Medicine Revenue, Price and Gross (2018-2023)
-
